Navigation Links
Patheon to Host Complimentary Seminar on “Getting Your Drug through Phase I Early Development Effectively” at Milton Park, UK Facility
Date:2/9/2013

(PRWEB) February 08, 2013

Patheon Inc., a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, today announced that it will be hosting a complimentary seminar on “Getting Your Drug Through Phase I Early Development Effectively”. The seminar will be held on Tuesday, February 19th at 11:30 – 6 p.m. Central European Time at Patheon’s Milton Park facility in Oxfordshire, UK.

Patheon recently announced its plans to launch the company’s SoluPath™ program at the Milton Park facility as part of the company’s global strategy to expand early pharmaceutical development services for its customers.

In the upcoming seminar, Patheon have invited three scientific leaders to share their experiences and answer questions on strategies for effectively progressing small molecules through early drug development. Presentations will be provided by Patheon employees, Jon Sutch, Ph.D., and Rick Bastin, as well as from Paul Madeley, Ph.D., with Synth-Isis Ltd. Through case studies and interactive presentations, presenters will discuss early stages of active pharmaceutical ingredient (API) development, formulation strategies and challenges of low solubility and bioavailability. There will also be an opportunity to pose technical questions to the company’s experts through the Ask the Experts round table. Visit Patheon’s website to learn more or register for the upcoming seminar.

About Patheon Inc.

Patheon Inc. (TSX: PTI) is a leading provider of contract developm
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Patheon Announces First Phase of Additional Investment in Milton Park, UK Facility to Expand Early Development Capabilities in Europe
2. Local Schools Infested With Bed Bugs, Faculty and Victims Receive Complimentary Bed Bug Spray Samples, MyCleaningProducts.com Explains
3. New No Scrubbing Rust Remover Being Offer As A Complimentary Sample To Save Contractors $1,000, My Cleaning Products Puts The Product To The Test
4. New Ordinance Holds Landlords Responsible To Kill Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Bully To Avoid High Exterminator Fee's
5. Medical Diagnostic Laboratories, L.L.C. Announces a Complimentary Reflex Test to Determine Azithromycin Resistance in Chlamydia Trachomatis
6. ComplianceOnline Announces Seminar on Statistical Analysis for Product Development
7. ComplianceOnline Announces Seminar on Clinical Trial Project Supplier Quality Improvement
8. iBioSeminars and iBioMagazine: Free, Online Biology Seminars and Short Talks by Leading Scientists
9. NSG Precision Cells Now Offering a High Grade Flow Through Cell with Unparalled Quality
10. Scientists Describe Breakthrough Technology for Brain Self-Optimization in Newly Published Paper
11. 3D printing breakthrough with human embryonic stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 Tauriga Sciences, ... diversified life sciences company, today announced that its stockholders ... of common stock of the Company from 1,000,000,000 to ... July 27, 2015 at the Law Offices of Nixon ... the Special Meeting, there were 480,655,929 shares of common ...
(Date:7/28/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS ) ... to German life sciences entrepreneurs with a proven ... biotechnology (collectively, the "Optionee"), an option to license ... technology (the "Technology"), including AEZS-120, the most advanced ... to enter a Phase 1 clinical trial. This ...
(Date:7/27/2015)... FRANKLIN, Tenn. , July 27, 2015 /PRNewswire/ ... health care services and one of the largest ... that its parent company and sole stockholder, Capella ... Medical Properties Trust, Inc. ("MPT") (NYSE: MPW ... cash.  The transaction is expected to be finalized ...
(Date:7/27/2015)...   Inocucor Technologies Inc ., the agriculture ... farmers, has received a notice of allowance from ... patent application to protect Inocucor consortia and unique ... yields on farms and in greenhouses. ... microbial consortium and its fermentation byproducts, which are ...
Breaking Biology Technology:Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 5Inocucor Technologies Receives Groundbreaking U.S. Patent for Proprietary Biological Processes that Stimulate Plant Growth 2Inocucor Technologies Receives Groundbreaking U.S. Patent for Proprietary Biological Processes that Stimulate Plant Growth 3
... In Lawsuit, CHICAGO, May 14 Last month ... on behalf of Davenport,Iowa resident, Mark Scott who suffered ... 30, 2007. The complaint was filed On April 1, ... Law Group and alleges that,Melissa Scott,s untimely death was ...
... Also Augments Senior Management Team with Recent Strategic Hires ... ... Rico, May 14 Triple-S,Management Corporation (NYSE: GTS ) today announced ... investigator for the Children,s Oncology Group and,the Dana Farber Acute Lymphoblastic Leukemia ...
... Ill., May 14 Sagent Pharmaceuticals, Inc.,a privately-held ... US$20,000 to the American Red Cross to assist ... "As a part of the global community, we ... of the Sichuan province," said Jeffrey M. Yordon,chief ...
Cached Biology Technology:Iowa Resident Dies After Using Contaminated Blood Thinner 2Iowa Resident Dies After Using Contaminated Blood Thinner 3Triple-S Management Corporation Appoints New Non-Executive Chairman to Board; Adds New Director 2
(Date:7/8/2015)... 2015  Trovagene, Inc. (NASDAQ: TROV ), ... the launch of a study that aims to ... (PCM) technology for predicting response to treatment in ... of the novel immunotherapy agents Yervoy® (ipilumumab), a ... The 50-patient study will be led by researchers ...
(Date:7/2/2015)... 25, 2015 Research ... of the "Natural Language Processing Market by ... OCR, Pattern & Image Recognition) - Worldwide Forecast ... The key vendors occupying the market are ... Microsoft Corporation, NetBase Solutions, SAS Institute Inc., Verint ...
(Date:6/29/2015)... 2015 Research and Markets( ... "Latin America Biomedical Sensors Market - Growth, Trends & ... The Latin America Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2
... people regain strength and normal use of affected hands ... California, Irvine study. , Stroke patients with ... release objects after therapy sessions using the Hand-Wrist Assisting ... residual weakness and reduced function of the right hand, ...
... The results of a new study suggest that bacteria ... illness can turn the genes that make them infectious ... Yersinia pestis and E. coli, do this may one ... of these genes, thereby making the bacteria harmless, said ...
... than what scientists had been assuming. A new study, appearing ... Chemistry, provides new information on the inner workings of cells ... make livers regrow in patients with liver diseases such as ... one of the few organs in the body that can ...
Cached Biology News:Robotic therapy helps restore hand use after stroke 2Robotic therapy helps restore hand use after stroke 3Bacteria control how infectious they become, study finds 2Bacteria control how infectious they become, study finds 3Liver regeneration may be simpler than previously thought 2Liver regeneration may be simpler than previously thought 3
... at the 9, 10, 12, and 13 positions. ... standard for the quantification of 13(S)-HODE by GC- ... of linoleic acid with plant and mammalian lipoxygenases. ... of tumor cells to the endothelium at concentrations ...
...
...
...
Biology Products: